Mediators of angiogenesis: The role of cellular adhesion molecules

被引:9
作者
Szekanecz, Z
Halloran, MM
Haskell, CJ
Shah, MR
Polverini, PJ
Koch, AE
机构
[1] Northwestern Univ, Sch Med, Dept Med, Sect Arthritis & Connect Tissue Dis, Chicago, IL 60611 USA
[2] Debrecen Univ Med, Dept Med 3, H-4004 Debrecen, Hungary
[3] Univ Michigan, Sch Dent, Lab Mol Pathogenesis, Ann Arbor, MI 48109 USA
[4] Lakeside Vet Adm Med Ctr, Chicago, IL 60611 USA
关键词
angiogenesis; angiogenic factors; cellular adhesion molecules; extracellular matrix; rheumatoid arthritis;
D O I
10.4052/tigg.11.73
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Angiogenesis, the production of new blood vessels, plays an important role in a number of physiological and pathological processes, such as development, tissue repair, inflammation, atherosclerosis and tumor progression. A number of mediators including cytokines, growth factors and others, have been implicated in angiogenesis. During tissue neovascularization, endothelial cells (EC) adhere to extracellular matrix (ECM) components and other ECs, which is an essential process in angiogenesis. Thus, in addition to soluble mediators mentioned above, ECM macromolecules and cellular adhesion molecules (CAMs) may also act as angiogenic factors. Among CAMs, E-selectin, vascular cell adhesion molecule (VCAM)-1, CD31, and some integrins may facilitate capillary formation both in vivo and in vitro. CAMs, as well as other angiogenic mediators may play a role in the pathogenesis of "angiogenic diseases". Targeting of any of these factors may have potential therapeutic relevance in such disorders.
引用
收藏
页码:73 / 93
页数:21
相关论文
共 127 条
  • [1] ISOLATION AND CULTURE OF SYNOVIAL MICROVASCULAR ENDOTHELIAL-CELLS - CHARACTERIZATION AND ASSESSMENT OF ADHESION MOLECULE EXPRESSION
    ABBOT, SE
    KAUL, A
    STEVENS, CR
    BLAKE, DR
    [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (04): : 401 - 406
  • [2] ALBELDA SM, 1993, LAB INVEST, V68, P4
  • [3] INTEGRINS AND OTHER CELL-ADHESION MOLECULES
    ALBELDA, SM
    BUCK, CA
    [J]. FASEB JOURNAL, 1990, 4 (11) : 2868 - 2880
  • [4] ALBELDA SM, 1991, EXS, V59, P188
  • [5] AMILORIDE INHIBITION OF ANGIOGENESIS IN-VITRO
    ALLIEGRO, MC
    ALLIEGRO, MA
    CRAGOE, EJ
    GLASER, BM
    [J]. JOURNAL OF EXPERIMENTAL ZOOLOGY, 1993, 267 (03): : 245 - 252
  • [6] HUMAN INTERFERON-INDUCIBLE PROTEIN-10 IS A POTENT INHIBITOR OF ANGIOGENESIS IN-VIVO
    ANGIOLILLO, AL
    SGADARI, C
    TAUB, DD
    LIAO, F
    FARBER, JM
    MAHESHWARI, S
    KLEINMAN, HK
    REAMAN, GH
    TOSATO, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (01) : 155 - 162
  • [7] ANGIOGENESIS INHIBITION - A REVIEW
    AUERBACH, W
    AUERBACH, R
    [J]. PHARMACOLOGY & THERAPEUTICS, 1994, 63 (03) : 265 - 311
  • [8] INVITRO MODEL OF ANGIOGENESIS USING A HUMAN ENDOTHELIUM-DERIVED PERMANENT CELL-LINE - CONTRIBUTIONS OF INDUCED GENE-EXPRESSION, G-PROTEINS, AND INTEGRINS
    BAUER, J
    MARGOLIS, M
    SCHREINER, C
    EDGELL, CJ
    AZIZKHAN, J
    LAZAROWSKI, E
    JULIANO, RL
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 1992, 153 (03) : 437 - 449
  • [9] BENNETT CF, 1994, J IMMUNOL, V152, P3530
  • [10] EXPRESSION OF PLATELET-ENDOTHELIAL CELL-ADHESION MOLECULE-1 (PECAM-1) DURING MELANOMA-INDUCED ANGIOGENESIS IN-VIVO
    BERGER, R
    ALBELDA, SM
    BERD, D
    IOFFREDA, M
    WHITAKER, D
    MURPHY, GF
    [J]. JOURNAL OF CUTANEOUS PATHOLOGY, 1993, 20 (05) : 399 - 406